Virtual Medicinal Product (VMP) - Reslizumab 25mg/2.5ml solution for infusion vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Reslizumab 25mg/2.5ml solution for infusion vials | Start Date 27-09-2017 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.5
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- R03DX08
- BNF Codes
-
- BNF code 03040200
| Code | Start Date | End Date |
|---|---|---|
| 34812511000001102 | 27-09-2017 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Reslizumab | Based on Ingredient Substance | 10 mg | 1 ml |
Name
Reslizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMReslizumab
-
VMP(Current) Reslizumab 25mg/2.5ml solution for i...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |